Abeona director gifts 500 company shares
Abeona Therapeutics director Mark Alvino reported a bona fide gift of 500 shares of Common Stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Abeona Therapeutics director Mark Alvino reported a bona fide gift of 500 shares of Common Stock. The gift was recorded at a price of $0.00 per share, reflecting a non-market, no‑consideration transfer. Following this disposition, he directly holds 77,065 shares of Abeona Therapeutics common stock.
Insider Trade Summary
500 shares gifted
Gift
1 txn
Insider
Alvino Mark
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 500 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 77,065 shares (Direct)
Holdings Before and After:
Common Stock, 77,565 to 77,065 shares (Direct)
Key Figures
Gifted shares: 500 shares
Gift price per share: $0.00 per share
Shares after transaction: 77,065 shares
+1 more
4 metrics
Gifted shares
500 shares
Bona fide gift of common stock on Form 4
Gift price per share
$0.00 per share
Reported value for the 500-share gift
Shares after transaction
77,065 shares
Direct holdings following the gift disposition
Transaction code
Code G (bona fide gift)
Non-derivative disposition classification
Key Terms
bona fide gift, Common Stock, Form 4
3 terms
bona fide gift financial
"transaction_code_description: "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Abeona Therapeutics (ABEO) director Mark Alvino report?
Director Mark Alvino reported a bona fide gift of 500 shares of Abeona Therapeutics common stock. The transaction was coded as a gift (Code G) and recorded at a per‑share price of $0.00, indicating no sale proceeds or market trade.
Was the Abeona Therapeutics (ABEO) insider transaction a market sale or purchase?
The transaction was not a market sale or purchase; it was a bona fide gift of 500 shares. The Form 4 lists a transaction price of $0.00 per share, confirming that no cash consideration changed hands in this disposition.
How is the Abeona Therapeutics (ABEO) insider transaction classified on the Form 4?
The transaction is classified as a non‑derivative disposition with code G, described as a bona fide gift. It involves 500 shares of common stock and is treated as a gift transfer rather than a typical open‑market trading activity.
Does the Form 4 for Abeona Therapeutics (ABEO) show any option exercises or derivative trades?
The Form 4 data shows no derivative transactions or option exercises. The derivativeSummary is empty, and the transactionSummary reports zero derivative transactions, indicating only the reported 500‑share gift of common stock occurred in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
